Healthcare Industry Reports

Reports > Healthcare > Selected Report

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Anthrax Vaccines Market Report for Forcast Period 2017 to 2022

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.

Scope of the Report:
This report focuses on the Anthrax Vaccines in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Live Vaccines
Cell free PA Vaccines

Market Segment by Applications, can be divided into
Human Use
Animal Use

There are 15 Chapters to deeply display the global Anthrax Vaccines market.

Chapter 1, to describe Anthrax Vaccines Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Anthrax Vaccines, with sales, revenue, and price of Anthrax Vaccines, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Anthrax Vaccines, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Anthrax Vaccines market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Anthrax Vaccines sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 Anthrax Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Live Vaccines
1.2.2 Cell free PA Vaccines
1.3 Market Analysis by Applications
1.3.1 Human Use
1.3.2 Animal Use
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Emergent BioSolutions
2.1.1 Business Overview
2.1.2 Anthrax Vaccines Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merial
2.2.1 Business Overview
2.2.2 Anthrax Vaccines Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Merial Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Merck
2.3.1 Business Overview
2.3.2 Anthrax Vaccines Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Merck Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Zoetis
2.4.1 Business Overview
2.4.2 Anthrax Vaccines Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Zoetis Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Bayer Sanidad Animal
2.5.1 Business Overview
2.5.2 Anthrax Vaccines Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Colorado Serum
2.6.1 Business Overview
2.6.2 Anthrax Vaccines Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Colorado Serum Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 PharmAthene
2.7.1 Business Overview
2.7.2 Anthrax Vaccines Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 PharmAthene Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Tiankang
2.8.1 Business Overview
2.8.2 Anthrax Vaccines Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Tiankang Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Biogénesis-Bago
2.9.1 Business Overview
2.9.2 Anthrax Vaccines Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 CAVAC
2.10.1 Business Overview
2.10.2 Anthrax Vaccines Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 CAVAC Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Rosenbusch
2.11.1 Business Overview
2.11.2 Anthrax Vaccines Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Rosenbusch Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Agrovet
2.12.1 Business Overview
2.12.2 Anthrax Vaccines Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Agrovet Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Vecol
2.13.1 Business Overview
2.13.2 Anthrax Vaccines Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Vecol Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 CVCRI
2.14.1 Business Overview
2.14.2 Anthrax Vaccines Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 CVCRI Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 IVPM
2.15.1 Business Overview
2.15.2 Anthrax Vaccines Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 IVPM Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Prondil
2.16.1 Business Overview
2.16.2 Anthrax Vaccines Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Prondil Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 CDV
2.17.1 Business Overview
2.17.2 Anthrax Vaccines Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 CDV Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Indian Immunologicals
2.18.1 Business Overview
2.18.2 Anthrax Vaccines Type and Applications
2.18.2.1 Type 1
2.18.2.2 Type 2
2.18.3 Indian Immunologicals Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Botswana Vaccine Institute
2.19.1 Business Overview
2.19.2 Anthrax Vaccines Type and Applications
2.19.2.1 Type 1
2.19.2.2 Type 2
2.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Ceva Santé Animale
2.20.1 Business Overview
2.20.2 Anthrax Vaccines Type and Applications
2.20.2.1 Type 1
2.20.2.2 Type 2
2.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Intervac
2.21.1 Business Overview
2.2.2 Anthrax Vaccines Type and Applications
2.21.2.1 Type 1
2.21.2.2 Type 2
2.21.3 Intervac Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 JOVAC
2.22.1 Business Overview
2.22.2 Anthrax Vaccines Type and Applications
2.22.2.1 Type 1
2.22.2.2 Type 2
2.22.3 JOVAC Anthrax Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Anthrax Vaccines Market Competition, by Manufacturer
3.1 Global Anthrax Vaccines Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Anthrax Vaccines Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Anthrax Vaccines Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Anthrax Vaccines Manufacturer Market Share
3.4.2 Top 5 Anthrax Vaccines Manufacturer Market Share
3.5 Market Competition Trend
4 Global Anthrax Vaccines Market Analysis by Regions
4.1 Global Anthrax Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Anthrax Vaccines Sales by Regions (2012-2017)
4.1.2 Global Anthrax Vaccines Revenue by Regions (2012-2017)
4.2 North America Anthrax Vaccines Sales and Growth (2012-2017)
4.3 Europe Anthrax Vaccines Sales and Growth (2012-2017)
4.4 Asia-Pacific Anthrax Vaccines Sales and Growth (2012-2017)
4.5 South America Anthrax Vaccines Sales and Growth (2012-2017)
4.6 Middle East and Africa Anthrax Vaccines Sales and Growth (2012-2017)
5 North America Anthrax Vaccines by Countries, Type, Application and Manufacturers
5.1 North America Anthrax Vaccines Sales, Revenue and Market Share by Countries
5.1.1 North America Anthrax Vaccines Sales by Countries (2012-2017)
5.1.2 North America Anthrax Vaccines Revenue by Countries (2012-2017)
5.1.3 USA Anthrax Vaccines Sales and Growth (2012-2017)
5.1.4 Canada Anthrax Vaccines Sales and Growth (2012-2017)
5.1.5 Mexico Anthrax Vaccines Sales and Growth (2012-2017)
5.2 North America Anthrax Vaccines Sales and Revenue (value) by Manufacturers (2016-2017)
5.2.1 North America Anthrax Vaccines Sales by Manufacturers (2016-2017)
5.2.2 North America Anthrax Vaccines Revenue by Manufacturers (2016-2017)
5.3 North America Anthrax Vaccines Sales by Type (2012-2017)
5.4 North America Anthrax Vaccines Sales by Application (2012-2017)
6 Europe Anthrax Vaccines by Countries, Type, Application and Manufacturers
6.1 Europe Anthrax Vaccines Sales, Revenue and Market Share by Countries
6.1.1 Europe Anthrax Vaccines Sales by Countries (2012-2017)
6.1.2 Europe Anthrax Vaccines Revenue by Countries (2012-2017)
6.1.3 Germany Anthrax Vaccines Sales and Growth (2012-2017)
6.1.4 UK Anthrax Vaccines Sales and Growth (2012-2017)
6.1.5 France Anthrax Vaccines Sales and Growth (2012-2017)
6.1.6 Russia Anthrax Vaccines Sales and Growth (2012-2017)
6.1.7 Italy Anthrax Vaccines Sales and Growth (2012-2017)
6.2 Europe Anthrax Vaccines Sales and Revenue (value) by Manufacturers (2016-2017)
6.2.1 Europe Anthrax Vaccines Sales by Manufacturers (2016-2017)
6.2.2 Europe Anthrax Vaccines Revenue by Manufacturers (2016-2017)
6.3 Europe Anthrax Vaccines Sales by Type (2012-2017)
6.4 Europe Anthrax Vaccines Sales by Application (2012-2017)
7 Asia-Pacific Anthrax Vaccines by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Anthrax Vaccines Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Anthrax Vaccines Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Anthrax Vaccines Revenue by Countries (2012-2017)
7.1.3 China Anthrax Vaccines Sales and Growth (2012-2017)
7.1.4 Japan Anthrax Vaccines Sales and Growth (2012-2017)
7.1.5 Korea Anthrax Vaccines Sales and Growth (2012-2017)
7.1.6 India Anthrax Vaccines Sales and Growth (2012-2017)
7.1.7 Southeast Asia Anthrax Vaccines Sales and Growth (2012-2017)
7.2 Asia-Pacific Anthrax Vaccines Sales and Revenue (value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Anthrax Vaccines Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Anthrax Vaccines Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Anthrax Vaccines Sales by Type (2012-2017)
7.4 Asia-Pacific Anthrax Vaccines Sales by Application (2012-2017)
8 South America Anthrax Vaccines by Countries, Type, Application and Manufacturers
8.1 South America Anthrax Vaccines Sales, Revenue and Market Share by Countries
8.1.1 South America Anthrax Vaccines Sales by Countries (2012-2017)
8.1.2 South America Anthrax Vaccines Revenue by Countries (2012-2017)
8.1.3 Brazil Anthrax Vaccines Sales and Growth (2012-2017)
8.1.4 Argentina Anthrax Vaccines Sales and Growth (2012-2017)
8.1.5 Columbia Anthrax Vaccines Sales and Growth (2012-2017)
8.2 South America Anthrax Vaccines Sales and Revenue (value) by Manufacturers (2016-2017)
8.2.1 South America Anthrax Vaccines Sales by Manufacturers (2016-2017)
8.2.2 South America Anthrax Vaccines Revenue by Manufacturers (2016-2017)
8.3 South America Anthrax Vaccines Sales by Type (2012-2017)
8.4 South America Anthrax Vaccines Sales by Application (2012-2017)
9 Middle East and Africa Anthrax Vaccines by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Anthrax Vaccines Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Anthrax Vaccines Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Anthrax Vaccines Revenue by Countries (2012-2017)
9.1.3 Saudi Arabia Anthrax Vaccines Sales and Growth (2012-2017)
9.1.4 UAE Anthrax Vaccines Sales and Growth (2012-2017)
9.1.5 Egypt Anthrax Vaccines Sales and Growth (2012-2017)
9.1.6 Nigeria Anthrax Vaccines Sales and Growth (2012-2017)
9.1.7 South Africa Anthrax Vaccines Sales and Growth (2012-2017)
9.2 Middle East and Africa Anthrax Vaccines Sales and Revenue (value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Anthrax Vaccines Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Anthrax Vaccines Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Anthrax Vaccines Sales by Type (2012-2017)
9.4 Middle East and Africa Anthrax Vaccines Sales by Application (2012-2017)
10 Global Anthrax Vaccines Market Segment by Type
10.1 Global Anthrax Vaccines Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Anthrax Vaccines Sales and Market Share by Type (2012-2017)
10.1.2 Global Anthrax Vaccines Revenue and Market Share by Type (2012-2017)
10.2 Live Vaccines Sales Growth and Price
10.2.1 Global Live Vaccines Sales Growth (2012-2017)
10.2.2 Global Live Vaccines Price (2012-2017)
10.3 Cell free PA Vaccines Sales Growth and Price
10.3.1 Global Cell free PA Vaccines Sales Growth (2012-2017)
10.3.2 Global Cell free PA Vaccines Price (2012-2017)
11 Global Anthrax Vaccines Market Segment by Application
11.1 Global Anthrax Vaccines Sales Market Share by Application (2012-2017)
11.2 Human Use Sales Growth (2012-2017)
11.3 Animal Use Sales Growth (2012-2017)
12 Anthrax Vaccines Market Forecast (2017-2022)
12.1 Global Anthrax Vaccines Sales, Revenue and Growth Rate (2017-2022)
12.2 Anthrax Vaccines Market Forecast by Regions (2017-2022)
12.2.1 North America Anthrax Vaccines Market Forecast (2017-2022)
12.2.2 Europe Anthrax Vaccines Market Forecast (2017-2022)
12.2.3 Asia-Pacific Anthrax Vaccines Market Forecast (2017-2022)
12.2.4 South America Anthrax Vaccines Market Forecast (2017-2022)
12.2.5 Middle East and Africa Anthrax Vaccines Market Forecast (2017-2022)
12.3 Anthrax Vaccines Market Forecast by Type (2017-2022)
12.4 Anthrax Vaccines Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

â–  Press releases, annual reports, Non-Profit organizations
â–  Industry associations, governmental agencies and customs data
â–  Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

â–  Product manufacturers
â–  Opinion leaders, industry experts and research institutions
â–  Distributors, Dealer and Traders
â–  Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 32816

Category: 11

Published date: 2017-09-18 02:55:21

Number of Pages: 117

Publisher Name: GIR (Global Info Research)

Over all Rating: 82 % (Average of Ratings provided by clients)